Compile Data Set for Download or QSAR

Found 29 hits of ic50 for UniProtKB: P00533   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494877 (US10994015, Example 11) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(CCOCCNc2cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c23)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.140	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494873 (US10994015, Example 7) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(CN2CCN(CCOCCOCCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)CC2)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495019 (US10994015, Example 319) Show SMILES CC(C)n1nc(N2CC(CN[C@H]3C[C@@H](C3)Oc3ccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c4c3)C2)c2cnc(Nc3ccnc(n3)-c3cnn(c3)S(=O)(=O)C3CC3)cc12 |r,wU:11.10,wD:13.15,(-8.98,2.82,;-10.07,3.91,;-11.56,3.51,;-9.67,5.39,;-8.26,6.02,;-8.42,7.55,;-7.28,8.58,;-7.28,10.12,;-5.74,10.12,;-4.64,11.25,;-3.15,10.87,;-2.07,11.97,;-1.59,13.44,;-.06,13.27,;-.56,11.65,;1.22,14.12,;2.56,13.35,;2.72,11.82,;4.12,11.2,;5.37,12.1,;6.88,11.78,;7.43,10.34,;7.65,13.11,;9.18,13.27,;10.08,12.03,;11.61,12.19,;12.24,13.6,;13.77,13.76,;11.34,14.84,;9.8,14.68,;8.9,15.93,;6.62,14.26,;6.86,15.78,;5.21,13.63,;3.8,14.26,;-5.74,8.58,;-9.93,7.87,;-10.7,9.21,;-12.24,9.21,;-13.01,7.87,;-14.55,7.87,;-15.32,6.54,;-16.86,6.54,;-17.63,5.2,;-16.86,3.87,;-15.32,3.87,;-14.55,5.2,;-14.55,2.54,;-13.02,2.38,;-12.7,.87,;-14.03,.1,;-15.18,1.13,;-14.19,-1.43,;-15.6,-2.06,;-12.95,-2.34,;-14.35,-2.96,;-15.5,-3.99,;-14.03,-4.47,;-12.24,6.54,;-10.7,6.54,)| Show InChI InChI=1S/C40H42N12O7S/c1-21(2)52-32-14-34(45-33-9-10-41-36(46-33)23-16-44-50(20-23)60(57,58)27-4-5-27)43-17-30(32)37(48-52)49-18-22(19-49)15-42-24-11-26(12-24)59-25-3-6-28-29(13-25)40(56)51(39(28)55)31-7-8-35(53)47-38(31)54/h3,6,9-10,13-14,16-17,20-22,24,26-27,31,42H,4-5,7-8,11-12,15,18-19H2,1-2H3,(H,47,53,54)(H,41,43,45,46)/t24-,26-,31?	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494874 (4-((17-(4-(4-(4-((2-chlorobenzyl)amino)-7H-pyrrolo...) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(CN2CCN(CCOCCOCCOCCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)CC2)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494875 (US10994015, Example 9) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(CN2CCN(CCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)CC2)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.90	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494867 ((2S,4R)-1-((S)-2-(tert-butyl)-14-(4-(4-(4-((2-chlo...) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCN2CCN(Cc3ccc(cc3)-c3cc4c(NCc5ccccc5Cl)ncnc4[nH]3)CC2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	2.10	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494872 (US10994015, Example 6) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(CN2CCN(CCOCCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)CC2)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.90	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494868 (US10994015, Example 2) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN2CCN(Cc3ccc(cc3)-c3cc4c(NCc5ccccc5Cl)ncnc4[nH]3)CC2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494871 (US10994015, Example 5) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCN2CCN(Cc3ccc(cc3)-c3cc4c(NCc5ccccc5Cl)ncnc4[nH]3)CC2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	4.10	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494870 (US10994015, Example 4) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCN2CCN(Cc3ccc(cc3)-c3cc4c(NCc5ccccc5Cl)ncnc4[nH]3)CC2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	4.20	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494869 (US10994015, Example 3) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCN2CCN(Cc3ccc(cc3)-c3cc4c(NCc5ccccc5Cl)ncnc4[nH]3)CC2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	5.5	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495017 (US10994015, Example 313 | US10994015, Example 314) Show SMILES CC(C)n1nc(N2CC(CN3CCN(CC4CCN(CC4)c4ccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c5c4)CC3)C2)c2cnc(Nc3ccnc(n3)-c3cnn(c3)S(=O)(=O)C3CC3)cc12 Show InChI InChI=1S/C46H54N14O6S/c1-28(2)60-38-20-40(50-39-9-12-47-42(51-39)31-21-49-58(27-31)67(65,66)33-4-5-33)48-22-36(38)43(53-60)57-25-30(26-57)24-55-17-15-54(16-18-55)23-29-10-13-56(14-11-29)32-3-6-34-35(19-32)46(64)59(45(34)63)37-7-8-41(61)52-44(37)62/h3,6,9,12,19-22,27-30,33,37H,4-5,7-8,10-11,13-18,23-26H2,1-2H3,(H,52,61,62)(H,47,48,50,51)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7.5	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494922 (US10994015, Example 13) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(OCCOCCNc2cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c23)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	37	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495012 (US10994015, Example 308) Show SMILES CC(C)n1nc(N2CC(CNCCCOCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(cc3)-c3scnc3C)C(C)(C)C)C2)c2cnc(Nc3ccnc(n3)-c3cnn(c3)S(=O)(=O)C3CC3)cc12 |r| Show InChI InChI=1S/C53H70N14O8S2/c1-32(2)67-42-22-45(60-44-15-17-55-49(61-44)38-24-58-66(28-38)77(72,73)40-13-14-40)56-25-41(42)50(63-67)64-26-35(27-64)23-54-16-8-18-74-19-20-75-30-46(69)62-48(53(5,6)7)52(71)65-29-39(68)21-43(65)51(70)59-33(3)36-9-11-37(12-10-36)47-34(4)57-31-76-47/h9-12,15,17,22,24-25,28,31-33,35,39-40,43,48,54,68H,8,13-14,16,18-21,23,26-27,29-30H2,1-7H3,(H,59,70)(H,62,69)(H,55,56,60,61)/t33-,39+,43-,48+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	53	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494879 (US10994015, Example 12) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(OCCOCCOCCNc2cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c23)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	83	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494924 (US10994015, Example 15) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOc2ccc(cc2)-c2cc3c(NCc4ccccc4Cl)ncnc3[nH]2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495016 (US10994015, Example 312) Show SMILES CC(C)n1nc(N2CCN(CC3CCN(CC3)c3ccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c4c3)CC2)c2cnc(Nc3ccnc(n3)-c3cnn(c3)S(=O)(=O)C3CC3)cc12 Show InChI InChI=1S/C42H47N13O6S/c1-25(2)55-34-20-36(46-35-9-12-43-38(47-35)27-21-45-53(24-27)62(60,61)29-4-5-29)44-22-32(34)39(49-55)52-17-15-50(16-18-52)23-26-10-13-51(14-11-26)28-3-6-30-31(19-28)42(59)54(41(30)58)33-7-8-37(56)48-40(33)57/h3,6,9,12,19-22,24-26,29,33H,4-5,7-8,10-11,13-18,23H2,1-2H3,(H,48,56,57)(H,43,44,46,47)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	170	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494923 ((2S,4R)-1-((S)-2-(tert-butyl)-14-(4-(4-((2-chlorob...) Show SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOc2ccc(cc2)-c2cc3c(NCc4ccccc4Cl)ncnc3[nH]2)C(C)(C)C)cc1 |r| Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495010 (US10994015, Example 306) Show SMILES CC(C)n1c(COCCN2CCN(CC2)c2ccc(OCCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(cc3)-c3scnc3C)C(C)(C)C)cc2)nc2cnc(Nc3ccnc(n3)-c3cnn(c3)S(=O)(=O)C3CC3)cc12 |r| Show InChI InChI=1S/C60H76N14O9S2/c1-38(2)74-49-30-52(67-51-19-20-61-57(68-51)43-31-64-73(33-43)85(79,80)47-17-18-47)62-32-48(49)66-53(74)35-82-28-25-70-21-23-71(24-22-70)44-13-15-46(16-14-44)83-27-8-26-81-36-54(76)69-56(60(5,6)7)59(78)72-34-45(75)29-50(72)58(77)65-39(3)41-9-11-42(12-10-41)55-40(4)63-37-84-55/h9-16,19-20,30-33,37-39,45,47,50,56,75H,8,17-18,21-29,34-36H2,1-7H3,(H,65,77)(H,69,76)(H,61,62,67,68)/t39-,45+,50-,56+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495005 (2-(2,6-dioxopiperidin-3-yl)-5-(4-(3-(4-(4-(2-((1-i...) Show SMILES COC1CCN(CC1)c1nccc(Nc2cc3n(C(C)C)c(COCCN4CCN(CC4)c4ccc(OCCCN5CCN(CC5)c5ccc6C(=O)N(C7CCC(=O)NC7=O)C(=O)c6c5)cc4)nc3cn2)n1 Show InChI InChI=1S/C52H65N13O7/c1-35(2)64-44-32-46(56-45-13-16-53-52(57-45)63-18-14-38(70-3)15-19-63)54-33-42(44)55-47(64)34-71-30-28-60-22-24-61(25-23-60)36-5-8-39(9-6-36)72-29-4-17-59-20-26-62(27-21-59)37-7-10-40-41(31-37)51(69)65(50(40)68)43-11-12-48(66)58-49(43)67/h5-10,13,16,31-33,35,38,43H,4,11-12,14-15,17-30,34H2,1-3H3,(H,58,66,67)(H,53,54,56,57)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495013 (US10994015, Example 309) Show SMILES C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CN1CCN(CCOCCOCCOCCOCC#Cc2cccc3CN(C(C(=O)Nc4nccs4)c4cc(F)ccc4O)C(=O)c23)CC1)C(C)(C)C)c1ccc(cc1)-c1scnc1C |r| Show InChI InChI=1S/C59H72FN9O11S2/c1-38(40-11-13-42(14-12-40)52-39(2)62-37-82-52)63-54(73)47-33-45(70)35-68(47)57(76)53(59(3,4)5)64-49(72)36-67-20-18-66(19-21-67)22-24-78-26-28-80-30-29-79-27-25-77-23-7-10-41-8-6-9-43-34-69(56(75)50(41)43)51(46-32-44(60)15-16-48(46)71)55(74)65-58-61-17-31-81-58/h6,8-9,11-17,31-32,37-38,45,47,51,53,70-71H,18-30,33-36H2,1-5H3,(H,63,73)(H,64,72)(H,61,65,74)/t38-,45+,47-,51?,53+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	1.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494876 (US10994015, Example 10) Show SMILES Clc1ccccc1CNc1ncnc2[nH]c(cc12)-c1ccc(OCCOCCOCCOCCNc2cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c23)cc1 Show InChI	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.70E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495011 (2-(7-((4-(3-(4-(4-(2-(2,6-dioxopiperidin-3-yl)-1,3...) Show SMILES Oc1ccc(F)cc1C(N1Cc2cccc(NCCCCOCCCN3CCC(CC3)N3CCN(CC3)c3ccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c4c3)c2C1=O)C(=O)Nc1nccs1 Show InChI InChI=1S/C48H54FN9O8S/c49-31-7-11-39(59)36(27-31)42(44(62)53-48-51-16-26-67-48)57-29-30-5-3-6-37(41(30)47(57)65)50-15-1-2-24-66-25-4-17-54-18-13-32(14-19-54)55-20-22-56(23-21-55)33-8-9-34-35(28-33)46(64)58(45(34)63)38-10-12-40(60)52-43(38)61/h3,5-9,11,16,26-28,32,38,42,50,59H,1-2,4,10,12-15,17-25,29H2,(H,51,53,62)(H,52,60,61)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.80E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495014 (US10994015, Example 310) Show SMILES C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)COCCOCCOCCN1CCN(CCOCC#Cc2cccc3CN(C(C(=O)Nc4nccs4)c4cc(F)ccc4O)C(=O)c23)CC1)C(C)(C)C)c1ccc(cc1)-c1scnc1C |r| Show InChI InChI=1S/C59H72FN9O11S2/c1-38(40-11-13-42(14-12-40)52-39(2)62-37-82-52)63-54(73)47-33-45(70)35-68(47)57(76)53(59(3,4)5)64-49(72)36-80-30-29-79-28-27-78-26-23-67-20-18-66(19-21-67)22-25-77-24-7-10-41-8-6-9-43-34-69(56(75)50(41)43)51(46-32-44(60)15-16-48(46)71)55(74)65-58-61-17-31-81-58/h6,8-9,11-17,31-32,37-38,45,47,51,53,70-71H,18-30,33-36H2,1-5H3,(H,63,73)(H,64,72)(H,61,65,74)/t38-,45+,47-,51?,53+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	6.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494931 (US10994015, Example 73) Show SMILES COC1CCN(CC1)c1nccc(Nc2cc3n(C(C)C)c(COCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](O)C[C@@H]4C(=O)N[C@@H](C)c4ccc(cc4)-c4scnc4C)C(C)(C)C)nc3cn2)n1 |r| Show InChI InChI=1S/C49H67N11O8S/c1-30(2)60-38-24-41(55-40-13-16-50-48(56-40)58-17-14-36(65-8)15-18-58)51-25-37(38)54-42(60)27-67-21-19-66-20-22-68-28-43(62)57-45(49(5,6)7)47(64)59-26-35(61)23-39(59)46(63)53-31(3)33-9-11-34(12-10-33)44-32(4)52-29-69-44/h9-13,16,24-25,29-31,35-36,39,45,61H,14-15,17-23,26-28H2,1-8H3,(H,53,63)(H,57,62)(H,50,51,55,56)/t31-,35-,39+,45+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495015 (US10994015, Example 311) Show SMILES C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)COCCN1CCN(CCOCCOCCOCC#Cc2cccc3CN(C(C(=O)Nc4nccs4)c4cc(F)ccc4O)C(=O)c23)CC1)C(C)(C)C)c1ccc(cc1)-c1scnc1C |r| Show InChI InChI=1S/C59H72FN9O11S2/c1-38(40-11-13-42(14-12-40)52-39(2)62-37-82-52)63-54(73)47-33-45(70)35-68(47)57(76)53(59(3,4)5)64-49(72)36-80-26-23-67-20-18-66(19-21-67)22-25-78-28-30-79-29-27-77-24-7-10-41-8-6-9-43-34-69(56(75)50(41)43)51(46-32-44(60)15-16-48(46)71)55(74)65-58-61-17-31-81-58/h6,8-9,11-17,31-32,37-38,45,47,51,53,70-71H,18-30,33-36H2,1-5H3,(H,63,73)(H,64,72)(H,61,65,74)/t38-,45+,47-,51?,53+/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	9.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM495017 (US10994015, Example 313 | US10994015, Example 314) Show SMILES CC(C)n1nc(N2CC(CN3CCN(CC4CCN(CC4)c4ccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c5c4)CC3)C2)c2cnc(Nc3ccnc(n3)-c3cnn(c3)S(=O)(=O)C3CC3)cc12 Show InChI InChI=1S/C46H54N14O6S/c1-28(2)60-38-20-40(50-39-9-12-47-42(51-39)31-21-49-58(27-31)67(65,66)33-4-5-33)48-22-36(38)43(53-60)57-25-30(26-57)24-55-17-15-54(16-18-55)23-29-10-13-56(14-11-29)32-3-6-34-35(19-32)46(64)59(45(34)63)37-7-8-41(61)52-44(37)62/h3,6,9,12,19-22,27-30,33,37H,4-5,7-8,10-11,13-18,23-26H2,1-2H3,(H,52,61,62)(H,47,48,50,51)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494928 (2-(2,6-dioxopiperidin-3-yl)-5-(2-(2-(2-((1-isoprop...) Show SMILES COC1CCN(CC1)c1nccc(Nc2cc3n(C(C)C)c(COCCOCCOCCOc4ccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c5c4)nc3cn2)n1 Show InChI InChI=1S/C39H47N9O9/c1-24(2)47-31-21-33(43-32-8-11-40-39(44-32)46-12-9-25(53-3)10-13-46)41-22-29(31)42-34(47)23-56-17-16-54-14-15-55-18-19-57-26-4-5-27-28(20-26)38(52)48(37(27)51)30-6-7-35(49)45-36(30)50/h4-5,8,11,20-22,24-25,30H,6-7,9-10,12-19,23H2,1-3H3,(H,45,49,50)(H,40,41,43,44)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>3.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair
Epidermal growth factor receptor [1-18,20-745,747-749,751-1210] (Homo sapiens (Human))	BDBM494929 (2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-((1-isopropyl-...) Show SMILES COC1CCN(CC1)c1nccc(Nc2cc3n(C(C)C)c(COCCN4CCN(CC4)c4ccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c5c4)nc3cn2)n1 Show InChI InChI=1S/C39H47N11O6/c1-24(2)49-31-21-33(43-32-8-11-40-39(44-32)48-12-9-26(55-3)10-13-48)41-22-29(31)42-34(49)23-56-19-18-46-14-16-47(17-15-46)25-4-5-27-28(20-25)38(54)50(37(27)53)30-6-7-35(51)45-36(30)52/h4-5,8,11,20-22,24,26,30H,6-7,9-10,12-19,23H2,1-3H3,(H,45,51,52)(H,40,41,43,44)	PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>3.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent					Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A...				US Patent US10994015 (2021) BindingDB Entry DOI: 10.7270/Q2NS0Z1G
					More data for this Ligand-Target Pair